- Home
- PLRZ vs TTNP Comparison
PLRZ vs TTNP Comparison
Compare PLRZ & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRZ
- TTNP
- Stock Information
- Founded
- PLRZ 2005
- TTNP 1991
- Country
- PLRZ Israel
- TTNP United States
- Employees
- PLRZ N/A
- TTNP N/A
- Industry
- PLRZ
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLRZ
- TTNP Health Care
- Exchange
- PLRZ NYSE
- TTNP Nasdaq
- Market Cap
- PLRZ 3.4M
- TTNP 3.7M
- IPO Year
- PLRZ 2024
- TTNP 1996
- Fundamental
- Price
- PLRZ $0.81
- TTNP $3.81
- Analyst Decision
- PLRZ
- TTNP
- Analyst Count
- PLRZ 0
- TTNP 0
- Target Price
- PLRZ N/A
- TTNP N/A
- AVG Volume (30 Days)
- PLRZ 639.1K
- TTNP 8.5K
- Earning Date
- PLRZ 11-25-2024
- TTNP 11-29-2024
- Dividend Yield
- PLRZ N/A
- TTNP N/A
- EPS Growth
- PLRZ N/A
- TTNP N/A
- EPS
- PLRZ N/A
- TTNP N/A
- Revenue
- PLRZ N/A
- TTNP $3,000.00
- Revenue This Year
- PLRZ N/A
- TTNP N/A
- Revenue Next Year
- PLRZ N/A
- TTNP N/A
- P/E Ratio
- PLRZ N/A
- TTNP N/A
- Revenue Growth
- PLRZ N/A
- TTNP N/A
- 52 Week Low
- PLRZ $0.77
- TTNP $3.57
- 52 Week High
- PLRZ $1.97
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- PLRZ N/A
- TTNP 34.23
- Support Level
- PLRZ N/A
- TTNP $3.77
- Resistance Level
- PLRZ N/A
- TTNP $4.66
- Average True Range (ATR)
- PLRZ 0.00
- TTNP 0.28
- MACD
- PLRZ 0.00
- TTNP 0.04
- Stochastic Oscillator
- PLRZ 0.00
- TTNP 3.93
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.